DAS28-ESR, SII, NHL score, NLR, ESR, CRP, proportion of neutrophils (%), and absolute count of neutrophils at the time of pretreatment with JAK inhibitors were significantly lower than the corresponding post-treatment values (p < 0.001 for all) (Table 4). The gene discussed is CRP; the disease is non-Hodgkin lymphoma.